|Bid||0.3200 x 0|
|Ask||0.3250 x 0|
|Day's Range||0.2950 - 0.3300|
|52 Week Range||0.1900 - 1.2200|
|Beta (5Y Monthly)||2.81|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 13, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||0.23|
NAPANEE, ON , Dec. 20, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today officially revealed its new Cannabis 2.0. VIVO will focus on the vape, chocolates and concentrates categories leveraging VIVO's premium adult-use cannabis brands including Canna Farms™ and Fireside™. The range of new products includes Canna Farms™ BC Kief, Canna Farms™ BC Bubble Hash, Canna Farms™ BC Live Rosin, and Canna Farms™ BC Hash Rosin.
Received conditional approval to graduate from the TSX Venture Exchange (the "TSXV") and list common shares on the Toronto Stock Exchange (the "TSX"). Completed first harvest at the new 86,000 square foot Kimmetts airhouse facility in Napanee, Ontario , following the issuance of a standard cultivation licence by Health Canada in August 2019 . Received a licence amendment to begin selling cannabis edibles, concentrates and topicals, with sales of premium cannabis chocolates, bubble hash, rosin, shatter, wax, vape pens and cartridges expected to commence in Ontario and other Canadian markets later this year or early in 2020.
NAPANEE, ON , Nov. 12, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to graduate from the TSX Venture Exchange (the "TSXV") and list its common shares on the TSX.
CB2 Insights (CSE: CBII) (OTCQB: CBIIF) has agreed to assist VIVO Cannabis (TSX-V: VIVO) (OTCQX: VVCIF) in the development of VIVO's global medical product development strategy. Under a technology and multi-phase research agreement, CB2 will be integrating its Clinical Data Management Software (CDMS) and Electronic Data Capture (EDC) tools to establish a better understanding of VIVO's current […]The post VIVO Partners CB2 Insights to Create Global Cannabis Product Strategy appeared first on Market Exclusive.
OTCQB: CBIIF) ("CB2"), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, announced it has entered into a technology and multi-phase research agreement with VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO"), an Ontario -based cannabis company recognized for its premium products and services, to assist in the development of VIVO's global medical product development strategy. Under the terms of the agreement, CB2 will be integrating CB2's Clinical Data Management Software (CDMS) and Electronic Data Capture (EDC) tools to establish better understanding of VIVO's current medical patient registry.
NAPANEE, ON , Oct. 3, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced it expects to commence first harvest at its Kimmetts facility in Napanee, Ontario in the fourth quarter of 2019. VIVO also unveiled its 2020 plans for the facility, which include an accelerated planting schedule and the contemplated use of five additional acres of land adjacent to the existing airhouses. The announcements were made during VIVO's analyst and investor day held in Napanee , where the Company showcased its airhouse technology, extraction programs and progress towards achieving EU GMP certification.
TORONTO , Sept. 19, 2019 /CNW/ - Cannabis Growth Opportunity Corporation ("CGOC", or the "Company") (CSE: CGOC), a cannabis-focused investment corporation with both public and private cannabis holdings, announces the company's updated net asset value per common share ("NAV") of $2.85 at the close of business on September 16, 2019 . This represents growth of 23% since the Initial Public Offering ("IPO"), on January 26, 2018 , and 3% year to date. CGOC's top ten public investments as of September 16, 2019 (in alphabetical order) are: Bhang Inc (CSE:BHNG), Grassroots Cannabis, (not yet listed), Heritage Cannabis (CSE:CANN), Jushi Holdings Inc. (NEO:JUSH.B), LPF Investment Corp. ("Loudpack", not yet listed) Next Green Wave (CSE:NGW), Planet 13 Holdings Inc. (CSE:PLTH), TerrAscend Corp. (CSE:TER), and VIVO Cannabis (VIVO.V).
NAPANEE, ON , Sept. 17, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced it has partnered with Linneo Health S.L. ("Linneo Health"), a subsidiary of Alcaliber S.A., to be its European medical cannabis supply partner. Linneo Health, a European leader in the pharmaceutical cannabis industry, recently received its EU-GMP (Good Manufacturing Practices) certification from the Spanish regulatory authorities. "Our partnership with Linneo Health is part of our strategic priority to accelerate international market growth," said Barry Fishman , Chief Executive Officer of VIVO.
Canopy Rivers (TSXV: RIV) (OTC: CNPOF) announced that its portfolio company TerrAscend (CSE: TER) (OTCQX: TRSSF) has signed agreements to acquire ABI SF, which operates a Bay Area cannabis cultivation facility and owns the State Flower brand. State Flower is known for its ultra-premium cannabis flower and is currently sold through dispensaries in California and Nevada. Vapen […]The post Cannabis Stock News Daily Roundup August 30 appeared first on Market Exclusive.
VIVO Cannabis Inc . (TSX-V: VIVO)(OTC: VVCIF) reported second-quarter net revenue of .3 million, five times higher than in the same quarter of 2018. The company had an adjusted EBITDA loss of $1.2 million ...
Health Canada approval was received to begin extraction operations using VIVO's on-site CO2 extraction system at the Napanee facility, and the Company has procured an ethanol system that will bring total extraction capacity to 50,000 kilograms per year. NAPANEE, ON , Aug. 28, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), today released its second quarter 2019 financial and operating results. "We remain focused on increasing long-term shareholder value by continuing to establish ourselves as a premium provider of cannabis products and services.
THCX Adds Companies Focused on CBD, Ancillary Services and Canadian Retail Market NEW YORK , Aug. 13, 2019 /PRNewswire/ -- Innovation Shares, a provider of thematic ETFs, announced it has completed the ...
NAPANEE, ON , Aug. 6, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that the Company's wholly-owned subsidiary, ABcann Medicinals Inc., has been granted a Standard Cultivation licence from Health Canada for its Kimmetts facility. Kimmetts, an innovative seasonal greenhouse site in Napanee, Ontario , is VIVO's third licensed production facility. The new site will increase the Company's annualized cultivation capacity by 4,000 kilograms, bringing its total internal licensed capacity to over 12,000 kilograms.
"We are extremely excited to commence CO2 extraction operations at our Napanee facility," said Gary McMullen , Vice-President, Napanee Operations. Upon receipt of EU-GMP certification for its Napanee facility, the Company is expected to be able to ship extracted cannabis products to Europe and other countries for scientific and medical purposes, subject to receipt of all necessary import and export permits, in addition to selling domestically.
VIVO Cannabis (TSX-V: VIVO) (OTCQX: VVCIF) has announced that it has made a C$1.25 million investment in Friendly Stranger Holdings, Canada's most iconic cannabis culture shop. The investment will facilitate Friendly Stranger's aggressive cannabis retail expansion plans, with a goal of bringing multiple retail stores to the Canadian market, VIVO said in a statement. "VIVO is […]The post VIVO Bullish on Cannabis Retailer Friendly Stranger appeared first on Market Exclusive.
NAPANEE, ON , June 20, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce that it has made a $1.25 million strategic investment in Friendly Stranger Holdings Corp. ("Friendly Stranger"), a longstanding retail champion of cannabis culture. "VIVO is focused on expanding capacity and increasing production capability to help meet the growing demand for cannabis among recreational users," stated Barry Fishman , Chief Executive Officer of VIVO. "Friendly Stranger has been an iconic brand in the Canadian cannabis sector for more than 25 years and we believe trusted retailers are integral to showcasing our premium family of brands, including Canna Farms™, Fireside™, and Lumina™.
NAPANEE, ON , June 12, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that the Company's wholly-owned subsidiary, ABcann Medicinals Inc., has received notification that its Kimmetts project has now advanced to the second phase of Health Canada's review and approval process. Kimmetts is being developed as a hybrid outdoor cultivation site, which currently houses four Airstream InnovationsTM environmental control shelters with 86,000 square feet of cultivation space. "Our airhouses are expected to capitalize on all the benefits and opportunities associated with growing outdoors (low capital and production costs, environmentally sustainable) with the added benefit of mitigating against the known challenges of producing high-quality cannabis outdoors," said Greg Yuristy , Director of Production for Napanee Operations.
NAPANEE, ON , June 5, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services for the medical and adult-use markets and licensed producer of cannabis under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited and ABcann Medicinals Inc., and its medical cannabis clinic network operated by Harvest Medicine Inc., today announced the results of its annual general and special meeting of shareholders held on June 4, 2019 (the "Meeting").